3E Bioventures
Finance · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.3ebio.comRevenue
<$5 MillionIndustry
About 3E Bioventures
3E Bioventures Org Chart
Is 3E Bioventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on 3E Bioventures recently announced quarterly report
Funding: Get notified immidiatlly once 3E Bioventures has new funding data
Product Launch: Get notified when 3E Bioventures launches new products
Check if 3E Bioventures has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at 3E Bioventures
3E Bioventures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if 3E Bioventures had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if 3E Bioventures is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to 3E Bioventures
Compare insights from companies similar to 3E Bioventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
3E Bioventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
3E Bioventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about 3E Bioventures.
3E Bioventures News & Media
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care - 3E Bioventures Capital and Beijing Whale Technology...Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its...Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy announces formation of joint venture company Beijing 3E-Regenacy with 3E Bioventures and start of Phase 2 study of ricolinostat for DPN
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 3E Bioventures
3E Bioventures takes on a science-driven, entrepreneur-friendly investment philosophy by working closely with companies and research institutions to develop drugs or products that have strong unmet medical needs. With offices in Beijing, Shanghai, and the San Francisco Bay Area, 3E Bioventures leverages its experience, capabilities, and network to... Read More